Filing Details
- Accession Number:
- 0001415889-25-005113
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-21 17:10:25
- Reporting Period:
- 2025-02-19
- Filing Date:
- 2025-02-21
- Accepted Time:
- 2025-02-21 17:10:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1907108 | Lexeo Therapeutics Inc. | LXEO | Biological Products, (No Disgnostic Substances) (2836) | 854012572 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1995218 | Nolan Richard Townsend | C/O Lexeo Therapeutics, Inc. 345 Park Avenue South, Floor 6 New York NY 10010 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-02-19 | 4,326 | $4.41 | 220,119 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").
- Includes 136,562 RSUs.
Billionaire Hedge Funds
